Actinium Pharmaceuticals reported $8.94M in Selling and Administration Expenses for its fiscal quarter ending in March of 2025.





Selling And Administration Expenses Change Date
AbbVie USD 3.89B 325M Dec/2025
Actinium Pharmaceuticals USD 8.94M 6.24M Mar/2025
Amgen USD 1.94B 237M Dec/2025
Bioline Rx USD 831K 622K Sep/2025
Capricor Therapeutics USD 5.88M 1.6M Mar/2025
Pfizer USD 4.08B 894M Dec/2025